“Glioblastoma multiforme (GBM) remains a lethal brain tumor characterized by poor response to chemotherapy and limited blood–brain barrier (BBB) permeability.”
BUFFALO, NY — May 21, 2026 — A new research paper was published in Volume 13 of Onco...
Following Impact Journals's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.
We will deliver them to your inbox, your phone, or you can use follow.it like your own online RSS reader. You can unsubscribe whenever you want with one click.
Keep up to date with Impact Journals!
Impact Journals: Impact Journals
Is this your feed? Claim it!
“Glioblastoma multiforme (GBM) remains a lethal brain tumor characterized by poor response to chemotherapy and limited blood–brain barrier (BBB) permeability.”
BUFFALO, NY — May 21, 2026 — A new research paper was published in Volume 13 of Onco...